Literature DB >> 4299730

A clinical trial of Glenn type 3 attenuated poliovirus vacine.

J M Barnes, C S Heymann, N S Galbraith, G R O'Moore.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1967        PMID: 4299730     DOI: 10.1007/bf01241949

Source DB:  PubMed          Journal:  Arch Gesamte Virusforsch        ISSN: 0003-9012


× No keyword cloud information.
  6 in total

1.  SURVEILLANCE OF THE SAFETY OF ORAL POLIOMYELITIS VACCINE IN ENGLAND AND WALES 1962-4.

Authors:  D L MILLER; N S GALBRAITH
Journal:  Br Med J       Date:  1965-08-28

2.  Present position of immunization against poliomyelitis with live virus vaccines.

Authors:  A B SABIN
Journal:  Br Med J       Date:  1959-03-14

3.  A small-scale trial of type III attenuated living poliovirus vaccine.

Authors:  S K CLARKE; A P GOFFE; C H STUART-HARRIS; E G HERZOG
Journal:  Br Med J       Date:  1958-11-15

4.  Mutants of poliomyelitis viruses with reduced efficiency of plating in acid medium and reduced neuropathogenicity.

Authors:  M VOGT; R DULBECCO; H A WENNER
Journal:  Virology       Date:  1957-08       Impact factor: 3.616

5.  Present status of attenuated live-virus poliomyelitis vaccine.

Authors:  A B SABIN
Journal:  J Am Med Assoc       Date:  1956-12-29

6.  A type 3 attenuated poliovirus genetically stable after human intestinal passage.

Authors:  S A PLOTKIN; T W NORTON; B J COHEN; H KOPROWSKI
Journal:  Proc Soc Exp Biol Med       Date:  1961 Aug-Sep
  6 in total
  1 in total

1.  Investigation of type 3 poliovirus variants with increased L-cystine-dependence as live vaccines.

Authors:  L B Elbert; M P Chumakov; G L Krutyanskaya; N M Ralph; A V Tyufanov; I S Sokolova; G A Alpatova
Journal:  Arch Gesamte Virusforsch       Date:  1971
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.